Longevity Net Receivables from 2010 to 2026
| XAGE Stock | 0.28 0.01 3.45% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 351.8 K | Current Value 280.8 K | Quarterly Volatility 44.4 K |
Check Longevity Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Longevity Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 161.3 K, Interest Expense of 41.9 K or Selling General Administrative of 2.9 M, as well as many indicators such as Price To Sales Ratio of 2.8 K, Dividend Yield of 0.0 or Days Sales Outstanding of 1.8 K. Longevity financial statements analysis is a perfect complement when working with Longevity Health Valuation or Volatility modules.
Longevity | Net Receivables | Build AI portfolio with Longevity Stock |
Analyzing Longevity Health's Net Receivables over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Receivables has evolved provides context for assessing Longevity Health's current valuation and future prospects.
Latest Longevity Health's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Longevity Health Holdings over the last few years. It is Longevity Health's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Longevity Health's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Longevity Net Receivables Regression Statistics
| Arithmetic Mean | 223,668 | |
| Geometric Mean | 220,316 | |
| Coefficient Of Variation | 19.86 | |
| Mean Deviation | 31,474 | |
| Median | 204,559 | |
| Standard Deviation | 44,416 | |
| Sample Variance | 2B | |
| Range | 147.3K | |
| R-Value | 0.63 | |
| Mean Square Error | 1.3B | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | 5,512 | |
| Total Sum of Squares | 31.6B |
Longevity Net Receivables History
About Longevity Health Financial Statements
Longevity Health stakeholders use historical fundamental indicators, such as Longevity Health's Net Receivables, to determine how well the company is positioned to perform in the future. Although Longevity Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Longevity Health's assets and liabilities are reflected in the revenues and expenses on Longevity Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Longevity Health Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 351.8 K | 280.8 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Longevity Health Holdings is a strong investment it is important to analyze Longevity Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Longevity Health's future performance. For an informed investment choice regarding Longevity Stock, refer to the following important reports:Check out the analysis of Longevity Health Correlation against competitors. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Will Biotechnology sector continue expanding? Could Longevity diversify its offerings? Factors like these will boost the valuation of Longevity Health. Anticipated expansion of Longevity directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Longevity Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Longevity Health Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Longevity Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Longevity Health's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Longevity Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longevity Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Longevity Health's market price signifies the transaction level at which participants voluntarily complete trades.